In last trading session, Annovis Bio Inc (NYSE:ANVS) saw 0.38 million shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $2.13 trading at -$0.1 or -4.48% at ring of the bell on the day assigns it a market valuation of $41.50M. That closing price of ANVS’s stock is at a discount of -838.97% from its 52-week high price of $20.00 and is indicating a premium of 2.35% from its 52-week low price of $2.08.
For Annovis Bio Inc (ANVS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.33. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.2 in the current quarter.
Annovis Bio Inc (NYSE:ANVS) trade information
Upright in the red during last session for losing -4.48%, in the last five days ANVS remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $2.13 price level, adding 23.66% to its value on the day. Annovis Bio Inc’s shares saw a change of -57.65% in year-to-date performance and have moved -18.08% in past 5-day. Annovis Bio Inc (NYSE:ANVS) showed a performance of -59.89% in past 30-days.
Wall Street analysts have assigned a consensus price target of 30 to the stock, which implies a rise of 92.9% to its current value. Analysts have been projecting 30 as a low price target for the stock while placing it at a high target of 30. It follows that stock’s current price would drop -1308.45% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1308.45% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -126.41% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 69.26% while estimates for its earnings growth in next 5 years are of 32.52%.
Annovis Bio Inc (NYSE:ANVS)’s Major holders
LMR PARTNERS LLP is the top institutional holder at ANVS for having 0.57 million shares of worth $3.3 million. And as of 2024-06-30, it was holding 5.0594 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 0.36 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.401 of outstanding shares, having a total worth of $2.08 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 263.51 shares of worth $0.56 million or 1.35% of the total outstanding shares. The later fund manager was in possession of 110.6 shares on Sep 30, 2024 , making its stake of worth around $0.24 million in the company or a holder of 0.57% of company’s stock.
